Ironwood Pharmaceuticals (IRWD) Accounts Payables (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Accounts Payables of $3.2 million for Q1 2026, up 11.7% sequentially from $2.9 million in Q4 2025, and down 44.45% YoY from $5.8 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Accounts Payables (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Accounts Payables for 17 years, with the latest figure at $3.2 million in Q1 2026.
- Quarterly Accounts Payables fell 44.45% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (down 44.45% YoY) and the FY2025 annual result came in at $2.9 million, up 36.25% from the prior year.
- Accounts Payables improved to $3.2 million in Q1 2026 per IRWD's latest filing, from $2.9 million in the prior quarter.
- Over five years, Accounts Payables peaked at $7.8 million in Q4 2023 and troughed at $118000.0 in Q1 2023.
- A 5-year average of $2.8 million and a median of $2.9 million in 2025 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2023 and 2024: Accounts Payables sank 77.82% in 2023, then jumped 5172.88% in 2024.
- Over 5 years, Accounts Payables stood at $483000.0 in 2022, then surged by 1521.12% to $7.8 million in 2023, then sank by 72.84% to $2.1 million in 2024, then jumped by 36.25% to $2.9 million in 2025, then grew by 11.7% to $3.2 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $3.2 million, $2.9 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 356.00 Mn |
| 10 | Ironwood Pharmaceuticals | 669.13 Mn | 590.00 Mn | - | 911,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 911,000.00 |
| Mar 31, 2026 | 3.24 Mn |
| Dec 31, 2025 | 2.90 Mn |
| Sep 30, 2025 | 1.61 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | 5.83 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 3.24 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Mar 31, 2024 | 6.22 Mn |
| Dec 31, 2023 | 7.83 Mn |
| Sep 30, 2023 | 4.70 Mn |
| Jun 30, 2023 | 3.51 Mn |
| Mar 31, 2023 | 118,000.00 |
| Dec 31, 2022 | 483,000.00 |
| Sep 30, 2022 | 795,000.00 |
| Jun 30, 2022 | 317,000.00 |
| Mar 31, 2022 | 532,000.00 |
| Dec 31, 2021 | 935,000.00 |
| Sep 30, 2021 | 414,000.00 |